Your browser doesn't support javascript.
loading
Initial treatment with a single capsule containing half-dose quadruple therapy vs standard-dose dual therapy in hypertensive patients (QUADUAL): Study protocol for a randomized, blinded, crossover trial.
Zhao, Xiexiong; Chen, Ye; Yang, Guoping; Li, Xingli; Tang, Xiaohong; Yang, Qiong; Peng, Liping; Li, Jingle; Liang, Zhongshu; Li, Anying; Wang, Wenjuan; Huang, Miao; Liu, Tao; Li, Xiaogang; Jiang, Weihong.
Afiliação
  • Zhao X; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Chen Y; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Yang G; Center of Clinical Pharmacology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China; Department of Clinical Pharmacology, Xiangya School of Pharmaceutical Sciences, Changsha, Hunan, China.
  • Li X; Department of Epidemiology, Xiangya School of Public Health, Changsha, Hunan, China.
  • Tang X; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Yang Q; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Peng L; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Li J; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Liang Z; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Li A; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Wang W; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Huang M; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Liu T; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Li X; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China. Electronic address: hnxylxg@csu.edu.cn.
  • Jiang W; Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China; Hypertension Research Center of Hunan Province, Changsha, Hunan, China. Electronic address: jiangweihongdoc@163.com.
Am Heart J ; 264: 10-19, 2023 10.
Article em En | MEDLINE | ID: mdl-37276913

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipertensão / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipertensão / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article